Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday.

The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday.

Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to fully replace revenue from best-sellers that go off-patent.

The Dow pared its gains in the final hour of trading after banking analyst Meredith Whitney said the recent market rally is not rooted in fundamentals and the U.S. economy is likely to fall back into a recession next year.

Stocks opened higher Monday, building on two weeks of gains, as a weak dollar boosted commodity stocks and a government report showed retail sales rose in October.

Stocks opened higher Monday, building on two weeks of gains, as a weak dollar boosted commodity stocks and a government report showed retail sales rose in October.

Bristol-Myers Squibb Co. shares will offer greater risks and rewards after the company completes its split from Mead Johnson Nutrition Co., a Credit Suisse analyst said Monday.

Stock index futures are pointing to a higher open Monday after data showed that Japan's economy grew nearly twice as much as expected in the third quarter.

Bristol-Myers Squibb said on Sunday it plans to split off its 83 percent stake in Mead Johnson Nutrition Company in a deal that lets Bristol shareholders exchange their shares for Mead Johnson common stock.

Bristol-Myers Squibb Co. is splitting off its holdings in infant formula maker Mead Johnson Nutrition Co. in order to focus on its biopharmaceutical business.

Heart attack patients in need of emergency procedures were less likely to suffer further serious cardiovascular events, including death, when given AstraZeneca's experimental Brilinta blood clot preventer than those who used Plavix, according to a study presented on Sunday.

The popular blood-thinner Plavix prevents heart attacks and strokes in both women and men, but the benefits differ slightly by gender, U.S. researchers said on Monday.

No doubt the widespread use of solar and wind power is ideal, but it’ll be a long time before the mass adoption of those alternative energies is a reality. In the meantime, Cramer says, the US should shift its focus to natural gas.

Johnson & Johnson will eliminate about 6 percent to 7 percent of its global workforce, or some 7,000 to 8,000 positions, as the diversified healthcare company restructures and seeks cost savings, the company said Tuesday.

Stocks advanced Thursday as investors seemed to focus more on some big-name earnings beats and a rise in leading indicators instead of a disappointing jobless report. Travelers and MMM led the Dow.